OBIO 8-K 2026-01-12

Orchestra BioMed Holdings, Inc. (OBIO) 8-K dated 2026-01-12 — accession 0001104659-26-002752. This URL is the filing, not the OBIO hub.

Orchestra BioMed Holdings, Inc. (OBIO) is a biotechnology company listed on NASDAQ.

Orchestra BioMed Holdings, Inc. filed a 8-K on 2026-01-12. Accession 0001104659-26-002752.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.

Not investment advice. The OBIO SEC hub lists recent forms. The stock page is the research view.